Core EM

OCTOBER 16, 2024

Author: Natalie Bertrand, MD Editor: Naillid Felipe, MD Background: Definition: adverse reaction to blood product administration Incidence: more common in children than adults, except for delayed hemolytic transfusion reactions Allergic (non-anaphylaxis) – Platelets 1-3%; RBCs 0.1-0.3%

Allergic Reaction 188

Allergic Reaction Plasma ED Epinephrine 188

Core EM

OCTOBER 2, 2024

Author: Natalie Bertrand, MD Editor: Naillid Felipe, MD Background: Definition: adverse reaction to blood product administration Incidence: more common in children than adults, except for delayed hemolytic transfusion reactions Allergic (non-anaphylaxis) – Platelets 1-3%; RBCs 0.1-0.3%

Allergic Reaction 100

Allergic Reaction Plasma ED Epinephrine 100

Medgadget

JUNE 13, 2022

The nanotechnological approach renders the treatment much safer, as previous attempts to use stem cell factor as a pro-angiogenic treatment have been hampered by severe allergic reactions in some recipients. Regenerative medicine holds enormous potential in treating patients who have suffered tissue damage after a cardiovascular event.

Allergic Reaction 63

Allergic Reaction Heart Attack OR 63

REBEL EM

SEPTEMBER 13, 2023

Urticaria and pruritus = MAST CELL mediated, which is treated like a standard allergic reaction. Urticaria and pruritus = MAST CELL mediated, which is treated like a standard allergic reaction. Understanding the cause of angioedema (mast cell vs. bradykinin mediated) helps dictate directed management.

Frozen Plasma 104

Frozen Plasma Allergic Reaction FFP Plasma 104

REBEL EM

JANUARY 23, 2023

Background: Diphenhydramine, a first-generation antihistamine, is the most common pharmacologic agent used to treat acute allergic reactions. T5 (3.9%) patients with adverse events were reported in the IV Cetirizine group compared to 18 (3.9%) in the IV diphenhydramine group. in the IV cetirizine group and 2.1 PMID: 17883909.

Allergic Reaction 52

Allergic Reaction ED E-9-1-1 Emergency Department 52

EMDocs

FEBRUARY 7, 2024

GLP-1 agonists are also associated with improved ejection fraction, coronary blood flow, and cardiac output while reducing the risk of cardiovascular events, infarction size, and all-cause mortality. Adverse events are common in those using GLP-1 agonists, but the vast majority of these are minor. Take for example semaglutide.

Allergic Reaction 98

Allergic Reaction ALS CAD OR 98

EMT Training Station

FEBRUARY 20, 2024

This information is crucial in avoiding allergic reactions, especially when administering emergency treatments. Events Leading Up to the Present Illness/Injury : The circumstances surrounding the onset of the patient’s current condition can offer valuable clues about the nature of the emergency.

EMT 96

EMT EMT Emergency Medical Services Allergic Reaction 96